Insider · CIK 0001581956

Biller Scott

Reports to the SEC for 2 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001581956

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+28K sh	$4.08	+$114K	28,000
2025-06-17	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	$4.79	+$120K	25,000
2024-06-26	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	$5.52	+$88.3K	16,000
2023-06-21	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-06-21	FHTXFoghorn Therapeutics Inc. · Stock Options (Right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2021-07-13	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,530
2019-06-11	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,218 sh	—	—	0
2019-06-11	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,218 sh	$2.34	+$16.9K	33,729
2019-04-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	$39.76	+$119K	29,511
2019-04-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−599 sh	$68.12	−$40.8K	26,511
2019-04-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	39,648
2019-04-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−2,401 sh	$67.61	−$162K	27,110
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−2,600 sh	$67.73	−$176K	26,711
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−200 sh	$66.45	−$13.3K	29,311
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+428 sh	$31.64	+$13.5K	26,939
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,572 sh	$39.76	+$102K	29,511
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,572 sh	—	—	42,648
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−428 sh	—	—	11,354
2019-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−200 sh	$68.22	−$13.6K	26,511
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,154 sh	$9.05	+$37.6K	32,431
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,154 sh	—	—	0
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,080 sh	—	—	11,782
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,080 sh	$31.64	+$97.5K	35,511
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,766 sh	$0.47	+$830.02	28,277
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,766 sh	—	—	0
2019-02-27	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−9,000 sh	$65.00	−$585K	26,511
2019-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2019-02-22	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Scientific Officer	AAward	+10K sh	—	—	10,000
2019-02-19	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Chief Scientific Officer	FTax Payment	−876 sh	$58.03	−$50.8K	26,511
2019-02-16	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,750 sh	—	—	5,500
2019-02-16	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,750 sh	—	—	27,387
2018-12-21	AGIOAGIOS PHARMACEUTICALS, INC. · Stock option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20.5K sh	—	—	7,218
2018-12-21	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20.5K sh	$2.34	+$47.9K	24,637
2018-11-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	4,154
2018-11-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−2,200 sh	$69.44	−$153K	51,732
2018-11-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−700 sh	$70.23	−$49.2K	51,032
2018-11-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−100 sh	$71.42	−$7,142	50,932
2018-11-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	$9.05	+$27.2K	53,932
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−979 sh	$69.47	−$68K	52,053
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−900 sh	$68.56	−$61.7K	53,032
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	$9.05	+$27.2K	53,932
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	7,154
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−21 sh	$71.77	−$1,507.17	50,932
2018-10-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−1,100 sh	$71.05	−$78.2K	50,953
2018-09-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−100 sh	$84.38	−$8,438	57,196
2018-09-05	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	10,154
2018-09-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−2,260 sh	$83.17	−$188K	57,296
2018-09-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Scientific Officer	SSale	−640 sh	$82.52	−$52.8K	59,556
2018-09-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,000 sh	$9.05	+$27.2K	60,196
2018-08-06	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,000 sh	—	—	13,154

Recent filings

Accepted (ET)
Jun 254
Biller Scott0001581956-26-000004
SEC(opens sec.gov)
Jun 174
Biller Scott0001562180-25-004899
SEC(opens sec.gov)
Jun 284
Biller Scott0001562180-24-005363
SEC(opens sec.gov)
Jun 224
Biller Scott0001562180-23-005477
SEC(opens sec.gov)
Jun 224
Biller Scott0001562180-22-005320
SEC(opens sec.gov)
Jul 144
Biller Scott0001562180-21-004931
SEC(opens sec.gov)
Jun 134
Biller Scott0001628280-19-007955
SEC(opens sec.gov)
Apr 94
Biller Scott0001209191-19-024105
SEC(opens sec.gov)
Mar 74
Biller Scott0001209191-19-017738
SEC(opens sec.gov)
Mar 14
Biller Scott0001209191-19-014933
SEC(opens sec.gov)

Companies

Address

99 COOLIDGE AVENUE STE 500

WATERTOWN, MA, 02472